1. Home
  2. IKT vs NEOV Comparison

IKT vs NEOV Comparison

Compare IKT & NEOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKT
  • NEOV
  • Stock Information
  • Founded
  • IKT 2008
  • NEOV 2018
  • Country
  • IKT United States
  • NEOV United States
  • Employees
  • IKT N/A
  • NEOV N/A
  • Industry
  • IKT Biotechnology: Pharmaceutical Preparations
  • NEOV Industrial Machinery/Components
  • Sector
  • IKT Health Care
  • NEOV Miscellaneous
  • Exchange
  • IKT Nasdaq
  • NEOV Nasdaq
  • Market Cap
  • IKT 123.7M
  • NEOV 148.1M
  • IPO Year
  • IKT 2020
  • NEOV N/A
  • Fundamental
  • Price
  • IKT $1.53
  • NEOV $3.99
  • Analyst Decision
  • IKT Buy
  • NEOV Hold
  • Analyst Count
  • IKT 2
  • NEOV 1
  • Target Price
  • IKT $8.00
  • NEOV N/A
  • AVG Volume (30 Days)
  • IKT 96.5K
  • NEOV 326.7K
  • Earning Date
  • IKT 11-13-2025
  • NEOV 11-07-2025
  • Dividend Yield
  • IKT N/A
  • NEOV N/A
  • EPS Growth
  • IKT N/A
  • NEOV N/A
  • EPS
  • IKT N/A
  • NEOV N/A
  • Revenue
  • IKT N/A
  • NEOV $8,426,835.00
  • Revenue This Year
  • IKT N/A
  • NEOV $91.25
  • Revenue Next Year
  • IKT N/A
  • NEOV $30.38
  • P/E Ratio
  • IKT N/A
  • NEOV N/A
  • Revenue Growth
  • IKT N/A
  • NEOV 218.59
  • 52 Week Low
  • IKT $1.42
  • NEOV $1.80
  • 52 Week High
  • IKT $4.20
  • NEOV $6.19
  • Technical
  • Relative Strength Index (RSI)
  • IKT 41.85
  • NEOV 36.82
  • Support Level
  • IKT $1.53
  • NEOV $4.16
  • Resistance Level
  • IKT $1.67
  • NEOV $4.58
  • Average True Range (ATR)
  • IKT 0.11
  • NEOV 0.51
  • MACD
  • IKT -0.00
  • NEOV -0.19
  • Stochastic Oscillator
  • IKT 19.64
  • NEOV 6.78

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About NEOV NeoVolta Inc.

NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.

Share on Social Networks: